-
Identifying risk factors and patterns for early recurrence of pancreatic neuroendocrine tumors: A multi-institutional study
Heidsma, C. M., Tsilimigras, D. I., Rocha, F., Abbott, D. E., Fields, R., Poultsides, G. A., Cho, C. S., Lopez-Aguiar, A. G., Kanji, Z., Fisher, A. V., Krasnick, B. A., Idrees, K., Makris, E., Beems, M., van Eijck, C. H. J., van Dijkum, E. J. M. N., Maithel, S. K. & Pawlik, T. M., 1 May 2021, In: Cancers. 13, 9, 2242.Research output: Contribution to journal › Article* › Academic › peer-review
-
Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumors
Heidsma, C. M., Tsilimigras, D. I., van Dieren, S., Rocha, F., Abbott, D. E., Fields, R., Smith, P. M., Poultsides, G. A., Cho, C., Dillhoff, M., Lopez-Aguiar, A. G., Kanji, Z., Fisher, A., Krasnick, B. A., Idrees, K., Makris, E., Beems, M., van Eijck, C. H. J., Nieveen van Dijkum, E. J. M. & Maithel, S. K. & 1 others, , Mar 2021, In: HPB: The official journal of the International Hepato Pancreato Biliary Association. 23, 3, p. 413-421 9 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
Hackeng, W. M., Brosens, L. A. A., Kim, J. Y., O'Sullivan, R., Sung, Y.-N., Liu, T.-C., Cao, D., Heayn, M., Brosnan-Cashman, J., An, S., Morsink, F. H. M., Heidsma, C. M., Valk, G. D., Vriens, M. R., Nieveen van Dijkum, E., Offerhaus, G. J. A., Dreijerink, K. M. A., Zeh, H., Zureikat, A. H. & Hogg, M. & 36 others, , 2021, (E-pub ahead of print) In: Gut.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
